Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 14 - Issue 6 - June 2017

Managing Aortic Arch Lesions: Experience With the Gore Thoracic Branch Endoprothesis
06/09/2017
The Gore Thoracic Branch Endoprothesis is a novel, single-branch stent-graft designed and initially studied for the treatment of thoracic aortic aneurysms in zone 2. We discuss the expansion of this device for use in zones 0 and 1.
The Gore Thoracic Branch Endoprothesis is a novel, single-branch stent-graft designed and initially studied for the treatment of thoracic aortic aneurysms in zone 2. We discuss the expansion of this device for use in zones 0 and 1.
The Gore Thoracic Branch...
06/09/2017
Vascular Disease Management
Tips for Contemporary Management of Congenital Arteriovenous Malformations
06/09/2017
Because the management of congenital arteriovenous malformation (CVM) falls within the purview of many medical specialties, it is critical to establish a multidisciplinary approach. This article offers tips for the diagnosis and treatment of...
Because the management of congenital arteriovenous malformation (CVM) falls within the purview of many medical specialties, it is critical to establish a multidisciplinary approach. This article offers tips for the diagnosis and treatment of...
Because the management of...
06/09/2017
Vascular Disease Management
Endovascular Therapy for Severe Pulmonary Embolism
06/09/2017
This article covers pulmonary embolism (PE) stratification, pathophysiology, and endovascular therapy for massive and submassive PE.
This article covers pulmonary embolism (PE) stratification, pathophysiology, and endovascular therapy for massive and submassive PE.
This article covers pulmonary...
06/09/2017
Vascular Disease Management
Section Editors Devoted to Increasing Studies in Areas of Great Interest to VDM Readers
06/08/2017
Dr. Craig Walker, Clinical Editor, welcomes three new Section Editors to the VDM team: Dr. Richard Kovach, section editor on Carotid Disease; Dr. Pradeep Nair, clinical section editor on New Technologies; and Dr. Amjad AlMahameed, section...
Dr. Craig Walker, Clinical Editor, welcomes three new Section Editors to the VDM team: Dr. Richard Kovach, section editor on Carotid Disease; Dr. Pradeep Nair, clinical section editor on New Technologies; and Dr. Amjad AlMahameed, section...
Dr. Craig Walker, Clinical...
06/08/2017
Vascular Disease Management
Access Site Problems Encountered More Frequently Today as Procedures Become More Complex
06/08/2017
Dr. Walker discusses this month’s article by Gupta, et al. and comments on the potential merit of a gel foam technique for treating patients with dangerous bleeds secondary to invasive procedures.
Dr. Walker discusses this month’s article by Gupta, et al. and comments on the potential merit of a gel foam technique for treating patients with dangerous bleeds secondary to invasive procedures.
Dr. Walker discusses this...
06/08/2017
Vascular Disease Management

Feature

Case Report
Endovascular Treatment of a Perforated Femoral Artery
06/08/2017
We describe here an endovascular approach to a perforation in the right femoral artery that was emergently closed with gel foam.
We describe here an endovascular approach to a perforation in the right femoral artery that was emergently closed with gel foam.
We describe here an endovascular...
06/08/2017
Vascular Disease Management
Original Research
A Multi-Regional Physician Survey of Peripheral Artery Disease: Implications for Improved Awareness and Expedited Referral
06/08/2017
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine...
06/08/2017
Vascular Disease Management
Original Research
A Multi-Regional Physician Survey of Peripheral Artery Disease: Implications for Improved Awareness and Expedited Referral
06/08/2017
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine...
06/08/2017
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

June 2017 Volume 14 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement